Skip to main content
Figure 1 | Trials

Figure 1

From: The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial

Figure 1

Flow chart of axillary reverse mapping (ARM) trial. ALND, Axillary lymph node dissection; cALND, complementary axillary lymph node dissection based on a tumor-positive sentinel node; pALND, primary axillary lymph node dissection based on a tumor-positive axilla proven by pre-operative cytology; ARM-ALND axillary lymph node dissection with preservation of the upper limb-related axillary lymph nodes; standard ALND, level I-II axillary lymph node dissection.

Back to article page

Trials

ISSN: 1745-6215